Ladores, Baby Girl .
HRN: 25-57-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
MUPIROCIN 2%, 15G (TUBE)
08/02/2024
08/08/2024
TOPICAL
2%, 15 G
BID
WOUND
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes